Skip to main content

Nonprofit · EIN 39-1554806

SOCIETY FOR IMMUNOTHERAPY OF CANCER INC

Tax-exempt · MILWAUKEE, WI 53202

Financials

$15.2M$15.3M2023$12.8M$14.1M2024
Revenue Expenses · by fiscal year end
Financials of SOCIETY FOR IMMUNOTHERAPY OF CANCER INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$12,836,586$14,136,449-$1,299,863$21,858,862$1,553,613$20,305,249
December 31, 2023990$15,211,563$15,284,371-$72,808$22,459,068$1,454,218$21,004,850
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$2,256,264
Program service revenue
$10,044,421
Investment income
$458,620
Royalties
$1,772
Net income from fundraising events
-$11,292
Net income from sales of inventory
$813
Other revenue
$77,281

Expenses

Grants and similar amounts paid
$908,704
Compensation of officers, directors and key employees
$5,000
Salaries, compensation and benefits (total)
$5,000
Professional fundraising fees
$0
Legal fees
$19,504
Accounting fees
$18,975
Travel
$688,123
Program services (functional)
$11,959,622
Management and general (functional)
$2,124,757
Fundraising (functional)
$52,070

Balance sheet and other

Total assets, start of year
$22,459,068
Total assets, end of year
$21,858,862
Total liabilities, end of year
$1,553,613
Net assets, end of year
$20,305,249
Publicly traded securities
$10,882,892
Net assets without donor restrictions
$17,174,187
Net assets with donor restrictions
$3,131,062
Gross unrelated business income
$73,000
Gross receipts
$12,891,156
Employees
0
Volunteers
259
Year formed
1986
State of legal domicile
WI

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
JENNIFER GUERRIERO PHDDIRECTOR
Trustee or director
1$2,000
TULLIA BRUNO PHDDIRECTOR
Trustee or director
1$2,000
CRYSTAL PAULOS PHDDIRECTOR
Trustee or director
1$1,000
LEISHA EMENS MD PHDPRESIDENT
Trustee or director, Officer
5$0
JAMES GULLEY MD PHDVICE PRESIDENT
Trustee or director, Officer
5$0
PATRICK HWU MDIMM. PAST PRES.
Trustee or director, Officer
5$0
JULIE BRAHMER MDDIRECTOR
Trustee or director
1$0
JENNIFER WARGO MD MMSCDIRECTOR
Trustee or director
1$0
JASON LUKE MD PHDDIRECTOR
Trustee or director
1$0
SARAH WARREN PHDDIRECTOR
Trustee or director
1$0
PAMELA OHASHI PHDSECR/TREASURER
Trustee or director, Officer
5$0
ARLENE SHARPE MD PHD FAIODIRECTOR
Trustee or director
1$0
AVERY POSEY JR PHDDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2023: 13 people
NameTitleHours / weekCompensation
CHRISTIAN CAPITINI MDDIRECTOR
Trustee or director
1$5,000
ANN SILK MD MSDIRECTOR
Trustee or director
1$3,000
ADEKUNLE ODUNSI MD PHD FRCOG FACODIRECTOR
Trustee or director
1$2,500
JENNIFER WARGO MD MMSCDIRECTOR
Trustee or director
1$2,000
JENNIFER GUERRIERO PHDDIRECTOR
Trustee or director
1$1,000
LEISHA EMENS MD PHDPRESIDENT
Trustee or director, Officer
5$750
JULIE BRAHMER MDDIRECTOR
Trustee or director
1$500
JAMES GULLEY MD PHDVICE PRESIDENT
Trustee or director, Officer
5$0
JEDD WOLCHOK MD PHDSECR/TREASURER
Trustee or director, Officer
5$0
PATRICK HWU MDIMM. PAST PRES.
Trustee or director, Officer
5$0
JASON LUKE MD PHDDIRECTOR
Trustee or director
1$0
SARAH WARREN PHDDIRECTOR
Trustee or director
1$0
TULIA BRUNO PHDDIRECTOR
Trustee or director
1$0

Address and contacts

Address (IRS master file)
555 E WELLS ST STE 1100, MILWAUKEE, WI 53202-3800
In care of
% TARA WITHINGTON
Principal officer (990 for 2024)
JAMES L GULLEY MD PHD, 555 E WELLS STREET 1100, MILWAUKEE, WI 53202
Signed the 990
PAMELA S OHASHI PHD, SECRETARY/TREASURER
Phone
(414) 271-2456
Return prepared by
RITZ HOLMAN LLP

Mission

TO IMPROVE CANCER PATIENT OUTCOMES BY ADVANCING THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH OUR CORE VALUES OF INTERACTION/INTEGRATION, INNOVATION, TRANSLATION, DIVERSITY AND INCLUSION AND LEADERSHIP IN THE FIELD. SITC AIMS TO MAKE CANCER IMMUNOTHERAPY A STANDARD OF CARE AND THE WORD "CURE" A REALITY FOR CANCER PATIENTS EVERYWHERE.

990 for the year ended December 31, 2024

Program accomplishments

  • THE SOCIETY FOR IMMUNOTHERAPY OF CANCER'S (SITC) 39TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2024) PROVIDED A MULTIDISCIPLINARY EDUCATIONAL AND INTERACTIVE ENVIRONMENT FOCUSED ON IMPROVING THE OUTCOME FOR CURRENT AND FUTURE PATIENTS WITH CANCER BY INCORPORATING STRATEGIES BASED ON BASIC AND APPLIED CANCER IMMUNOTHERAPY. THE ANNUAL MEETING CONSISTED OF CUTTING-EDGE RESEARCH PRESENTATIONS BY EXPERTS IN THE FIELD, ORAL AND POSTER ABSTRACT PRESENTATIONS AND AMPLE OPPORTUNITY FOR STRUCTURED AND INFORMAL DISCUSSIONS, INCLUDING IMPORTANT NETWORKING OPPORTUNITIES. IN ADDITION, THE MEETING INCLUDES UPDATES ON MAJOR NATIONAL AND INTERNATIONAL INITIATIVES COMING FROM ACADEMIA, GOVERNMENT AND INDUSTRY, AS WELL AS IMPORTANT SOCIETY PROJECTS.
    Expenses $6,261,769 · revenue $6,409,534
  • CIG PROGRAM - THE SITC CANCER IMMUNOTHERAPY GUIDELINES PROGRAM IS A COLLECTION OF CLINICAL PRACTICE GUIDELINES (CPGS) DEVELOPED BY MULTI-DISCIPLINARY PANELS OF EXPERTS WHO DRAW FROM THEIR OWN PRACTICAL EXPERIENCE AS WELL AS EVIDENCE IN THE PUBLISHED LITERATURE AND CLINICAL TRIAL DATA TO DEVELOP EVIDENCE- AND CONSENSUS-BASED RECOMMENDATIONS ON WHEN AND HOW TO USE IMMUNOTHERAPY TO HELP IMPROVE OUTCOMES FOR PATIENTS WITH CANCER. THESE CPGS OFFER A VITAL RESOURCE FOR THE PRACTICING ONCOLOGY COMMUNITY. SITC USES AS A MODEL THE INSTITUTE OF MEDICINE'S 2011 "STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES" TO ENSURE A FAIR, TRANSPARENT AND BALANCED PROCESS FOR CREATING THE CPGS. EACH CPG EXPERT PANEL IS COMPRISED OF A COMPREHENSIVE MIX OF ACADEMIC PHYSICIANS AND RESEARCHERS, NURSES, PATIENTS, AND PATIENT ADVOCATES INVITED FROM INSTITUTIONS ACROSS THE UNITED STATES.
    Expenses $618,457
  • THE ADVANCES IN CANCER IMMUNOTHERAPY (ACI) SERIES HOSTED TEN CME-, CNE-, CPE-, AND MOC- CERTIFIED PROGRAMS IN 2024. TWO OF THE PROGRAMS WERE HELD IN PERSON AT SUBSPECIALTY GROUP MEETINGS, AND EIGHT OF THE PROGRAMS WERE HELD VIRTUALLY ONLY. THE SERIES WAS DESIGNED TO PROVIDE EDUCATION TO PATIENT CARE PROVIDERS AND OTHERS WHO WISH TO LEARN THE BASIC PRINCIPLES OF TUMOR IMMUNOLOGY AND IMMUNOTHERAPY, AND TO IMPROVE THEIR ABILITY TO INTEGRATE IMMUNOTHERAPY INTO STATE-OF-THE-ART CLINICAL MANAGEMENT FOR THEIR PATIENTS. THIS INTENDED AUDIENCE INCLUDED CLINICAL ONCOLOGISTS, REGISTERED NURSES, ADVANCED PRACTITIONERS, PHARMACISTS, EMERGENCY PHYSICIANS, PATHOLOGISTS, SURGEONS, RADIATION ONCOLOGISTS, ALLIED HEALTH PROFESSIONALS, AND OTHER PATIENT CARE PROVIDERS, STUDENTS AND PATIENT ADVOCATES.
    Expenses $354,970 · revenue $20,930
  • WORKSHOP / CONNECTED / PRIMER / WIC/ INDUSTRY / WINTER / WIN / SPAKATHON PROGRAM / JOURNAL / COLLABORATIVE EDUCATION PROGRAMS / CIG / POLICY ACTIVITIES / SCIENTIFIC RESOURCES / CERTIFICATE PROGRAM / DIVERSITY, EQUITY AND INCLUSION / ENGINEERING AND IO / FAIO / OTHER PROGRAM SERVICES
    Expenses $4,724,426 · grants $908,704 · revenue $3,627,758

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
39-1554806
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1993
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$21,858,862
Income (IRS master file)
$12,891,156

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$12,836,586$14,136,449$21,858,862XML
990-TDecember 2024–––IRS
990December 2023$15,211,563$15,284,371$22,459,068XML
990-TDecember 2023–––IRS
990December 2022$17,242,766$14,244,820$24,306,761IRS
990-TDecember 2022–––IRS
990December 2021–––IRS
990-TDecember 2021–––IRS
990December 2020–––IRS
990-TDecember 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 39-1554806).

Questions about SOCIETY FOR IMMUNOTHERAPY OF CANCER INC

What is the EIN of SOCIETY FOR IMMUNOTHERAPY OF CANCER INC?
The employer identification number (EIN) of SOCIETY FOR IMMUNOTHERAPY OF CANCER INC is 39-1554806.
Is SOCIETY FOR IMMUNOTHERAPY OF CANCER INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1993.
Are donations to SOCIETY FOR IMMUNOTHERAPY OF CANCER INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does SOCIETY FOR IMMUNOTHERAPY OF CANCER INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of SOCIETY FOR IMMUNOTHERAPY OF CANCER INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did SOCIETY FOR IMMUNOTHERAPY OF CANCER INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of SOCIETY FOR IMMUNOTHERAPY OF CANCER INC?
The 990 for the year ended December 31, 2024 names JAMES L GULLEY MD PHD.
Who are the officers and directors of SOCIETY FOR IMMUNOTHERAPY OF CANCER INC?
The 990 for the year ended December 31, 2024 lists 13 people; 3 received compensation from the organization, the highest $2,000 (JENNIFER GUERRIERO PHD, DIRECTOR).
How much revenue does SOCIETY FOR IMMUNOTHERAPY OF CANCER INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $12,836,586, expenses of $14,136,449 and total assets of $21,858,862 at year end.

Other nonprofits in MILWAUKEE

All nonprofits in MILWAUKEE · Wisconsin